TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ARDX

Ardelyx Inc

Healthcare · Biotechnology

3.40$ -0.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Ardelyx Inc (ARDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 407 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARDX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
32 24 24 42 2.6 5.3 7.6 10 52 124 334 407
33 1.3 1.3 8.4 0.5 0.6 0.1 1.0 4.1 18 51 43
32 24 23 34 2.1 4.7 7.4 9.1 48 107 283 365
26 40 94 75 69 72 65 91 35 36 52 68
7.3 14 19 23 24 24 33 72 77 134 259 337
33 53 113 99 93 96 98 163 112 170 311 406
-1.6 -29 -113 -65 -91 -91 -91 -154 -64 -63 -28 -41
0.0 0.0 0.0 0.0 3.5 5.7 5.1 4.5 5.1 8.9 20 28
-3.1 -30 -112 -63 -91 -95 -94 -158 -67 -66 -39 -61
0.1 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.5 0.3 1.0
-3.2 -30 -112 -64 -91 -95 -94 -158 -67 -66 -39 -62
-1.3 -29 -112 -62 -85 -85 -85 -151 -61 -55 -17 -29

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?